Efficacy of Seroquel SR in combination with an antidepressant in treatment of Major Depressive Disorder - ONYX

Study identifier:D1448C00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination with an Antidepressant in the Treatment of Patients with Major Depressive Disorder with Inadequate Response to an Antidepressant Treatment

Medical condition

Major depressive disorder

Phase

Phase 3

Healthy volunteers

No

Study drug

Quetiapine, Amitriptyline, Bupropion, Citalopram, Duloxetine, Escitalopram, Fluoxetine, Paroxetine, Sertraline, Venlafaxine

Sex

All

Actual Enrollment

494

Study type

Interventional

Age

18 Years - 65 Years

Date

Study Start Date: 01 May 2006
Primary Completion Date: -
Study Completion Date: 01 Apr 2007

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria